Please login to the form below

Not currently logged in
Email:
Password:

Anti-amyloid drugs

This page shows the latest Anti-amyloid drugs news and features for those working in and with pharma, biotech and healthcare.

Double blow to amyloid drug hopes as Roche, Lilly trial fails

Double blow to amyloid drug hopes as Roche, Lilly trial fails

The two investigational candidates were unable to show benefit. A clinical trial of Roche and Eli Lilly anti-amyloid drugs in inherited forms of Alzheimer’s disease has ended in failure, ... Roche is also running a trial of another anti-amyloid

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    Whether the reduction of tau. load in patient brains will create a similar or even larger treatment effect than anti-amyloid drugs will become clearer with ongoing trials. ... Positron Emission Imaging (PET) – we can better select patients for either

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    A clutch of drugs with anti-amyloid mechanisms are in phase 2 and 3 trials. ... In 2019, amyloid drugs accounted for 24% of the phase 2 pipeline, down from 30% one year earlier.

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    dead. At the CTAD meeting, data was presented on other anti-amyloid drugs which their makers hope will end the search for disease-modifying treatments for the disease. ... Prof Gordon Wilcock at the University of Oxford said: “It may be that

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...